JP2011528688A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528688A5
JP2011528688A5 JP2011519144A JP2011519144A JP2011528688A5 JP 2011528688 A5 JP2011528688 A5 JP 2011528688A5 JP 2011519144 A JP2011519144 A JP 2011519144A JP 2011519144 A JP2011519144 A JP 2011519144A JP 2011528688 A5 JP2011528688 A5 JP 2011528688A5
Authority
JP
Japan
Prior art keywords
group
alkyl
compound
linear
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011519144A
Other languages
English (en)
Japanese (ja)
Other versions
JP5619740B2 (ja
JP2011528688A (ja
Filing date
Publication date
Priority claimed from EP08160856A external-priority patent/EP2147684A1/en
Application filed filed Critical
Publication of JP2011528688A publication Critical patent/JP2011528688A/ja
Publication of JP2011528688A5 publication Critical patent/JP2011528688A5/ja
Application granted granted Critical
Publication of JP5619740B2 publication Critical patent/JP5619740B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011519144A 2008-07-22 2009-07-21 メタロプロテアーゼの選択的診断剤 Expired - Fee Related JP5619740B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08160856.4 2008-07-22
EP08160856A EP2147684A1 (en) 2008-07-22 2008-07-22 Diagnostic Agents Selective Against Metalloproteases
PCT/EP2009/059338 WO2010010079A1 (en) 2008-07-22 2009-07-21 Diagnostic agents selective against metalloproteases

Publications (3)

Publication Number Publication Date
JP2011528688A JP2011528688A (ja) 2011-11-24
JP2011528688A5 true JP2011528688A5 (cg-RX-API-DMAC10.html) 2012-01-12
JP5619740B2 JP5619740B2 (ja) 2014-11-05

Family

ID=39737623

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011519144A Expired - Fee Related JP5619740B2 (ja) 2008-07-22 2009-07-21 メタロプロテアーゼの選択的診断剤

Country Status (5)

Country Link
US (1) US9480758B2 (cg-RX-API-DMAC10.html)
EP (2) EP2147684A1 (cg-RX-API-DMAC10.html)
JP (1) JP5619740B2 (cg-RX-API-DMAC10.html)
CN (1) CN102105174B (cg-RX-API-DMAC10.html)
WO (1) WO2010010079A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3003395B1 (en) * 2013-05-30 2019-07-17 Bracco Imaging S.p.A Fluorescent solid lipid nanoparticles composition and preparation thereof
WO2018204872A2 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
AU2018261888B2 (en) 2017-05-05 2022-06-30 Centre For Probe Development And Commercialization Pharmacokinetic enhancements of bifunctional chelates and uses thereof
CN117957214A (zh) * 2021-05-13 2024-04-30 总医院公司 用于醛类的体内检测的分子探针

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US5362476A (en) 1984-10-18 1994-11-08 Board Of Regents, The University Of Texas System Alkyl phosphonate polyazamacrocyclic cheates for MRI
MX174467B (es) 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
IT1213029B (it) 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5021556A (en) 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US5075099A (en) 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5118797A (en) 1989-08-28 1992-06-02 E. R. Squibb & Sons, Inc. Rhenium tris dioxime complexes
CA2034042C (en) 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5183653A (en) 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US5367080A (en) 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5965107A (en) 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
JP2774378B2 (ja) 1991-02-08 1998-07-09 ダイアテク,インコーポレイテッド 映像用テクネチウム−99m標識化ポリペプチド
US5849261A (en) 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5808091A (en) 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5608110A (en) 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
AU7261994A (en) 1993-07-19 1995-02-20 Resolution Pharmaceuticals Inc. Hydrazino-type radionuclide chelators having an n3s configuration
US5409689A (en) 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US5574140A (en) 1993-09-03 1996-11-12 Resolution Pharmaceutical Inc. Hydrazino-type N2 S2 chelators
US5662885A (en) 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US6333021B1 (en) 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
DE4445065A1 (de) 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
GB9502065D0 (en) 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
EA003294B1 (ru) * 1995-12-08 2003-04-24 Агурон Фармасьютикалс, Инк. Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
NZ325939A (en) * 1996-01-23 2000-06-23 Shionogi & Co Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives
JP3795339B2 (ja) * 1996-01-23 2006-07-12 塩野義製薬株式会社 スルホン化されたアミノ酸誘導体およびそれを含有するメタロプロティナーゼ阻害剤
ES2206689T3 (es) 1996-10-28 2004-05-16 Amersham Health As Agentes de contraste.
WO1998018498A2 (en) 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
ATE314097T1 (de) 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
EP0973552B1 (en) 1996-10-28 2006-03-01 Amersham Health AS Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0983267B1 (en) 1997-03-04 2005-01-26 Pharmacia Corporation Amidoaromatic ring sulfonamide hydroxamic acid compounds
US5985900A (en) 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
DE19717904A1 (de) 1997-04-23 1998-10-29 Diagnostikforschung Inst Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
US5886142A (en) 1997-05-20 1999-03-23 Thomas Jefferson University Radiolabeled thrombus imaging agents
US6245318B1 (en) 1997-05-27 2001-06-12 Mallinckrodt Inc. Selectively binding ultrasound contrast agents
GB9712525D0 (en) 1997-06-16 1997-08-20 Nycomed Imaging As Method
GB9725782D0 (en) 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
PL342009A1 (en) 1998-02-04 2001-05-07 Novartis Ag Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases
KR100279519B1 (ko) * 1998-02-18 2001-02-01 이본수 비산계니트로화공정에의한방향족화합물의니트로화방법
PT977745E (pt) * 1998-03-04 2005-04-29 Pharmacia Corp Compostos de acido tioarilo sulfonamida hidroxamico
RU2217418C2 (ru) 1998-04-03 2003-11-27 Санкио Компани, Лимитед Сульфонамидное производное, лекарственное средство, способы лечения
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
US6800646B1 (en) 1999-02-08 2004-10-05 Pharmacia Corporation Sulfamato hydroxamic acid metalloprotease inhibitor
WO2003000830A1 (en) 1999-12-09 2003-01-03 Texas Petrochemicals Lp Low lead aviation gasoline blend
IT1315263B1 (it) 1999-12-21 2003-02-03 Bracco Spa Composti chelanti,loro chelati con ioni metallici paramagnetici, loropreparazione ed uso
US7790144B2 (en) * 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
IT1317862B1 (it) 2000-02-29 2003-07-15 Bracco Spa Coniugati di acidi biliari con chelati complessi di ioni metallici eloro uso.
KR20030005230A (ko) 2000-03-21 2003-01-17 더 프록터 앤드 갬블 캄파니 N-치환된 메탈로프로테아제 저해제를 함유하는 탄소환식측쇄
MXPA01013326A (es) 2001-02-14 2002-08-26 Warner Lambert Co Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
ITMI20011518A1 (it) 2001-07-17 2003-01-17 Bracco Imaging Spa Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia
US20060093552A1 (en) * 2002-03-11 2006-05-04 Molecular Insight Pharmaceuticals, Inc. Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
TW200305396A (en) * 2002-03-27 2003-11-01 Shionogi & Co Cartilage extracellular matrix degradation
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
EP1592458A1 (en) * 2003-02-10 2005-11-09 GE Healthcare Limited Diagnostic imaging agents with mmp inhibitory activity
GB0302891D0 (en) * 2003-02-10 2003-03-12 Amersham Plc Diagnostic imaging agents for cardiovascular disease
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
BR0318625A (pt) 2003-12-04 2006-10-31 Wyeth Corp biaril sulfonamidas e métodos para usar as mesmas
US20080124270A1 (en) 2003-12-23 2008-05-29 Bracco Imaging S.P.A. Compounds Useful as Metal Chelators
US7749485B2 (en) 2004-06-03 2010-07-06 Bracco Research S.A. Liposomal assembly for therapeutic and/or diagnostic use
EP1765812B1 (en) 2004-07-02 2009-04-29 Bracco Imaging S.p.A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
GB0421308D0 (en) 2004-09-24 2004-10-27 Amersham Plc Enzyme inhibitor imaging agents
GB0428012D0 (en) * 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
ITTO20060575A1 (it) * 2006-08-02 2008-02-03 Univ Pisa Inibitori di zinco proteinasi tioaril sostituiti e loro usi
EP1972617A1 (en) * 2007-03-19 2008-09-24 Bracco Imaging, S.P.A. Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors

Similar Documents

Publication Publication Date Title
CN106132960B (zh) 用作蛋白质聚集抑制剂的杂芳基酰胺
ES2906379T3 (es) Agonistas de PPAR, compuestos, composiciones farmacéuticas y métodos de uso de los mismos
RU2009105179A (ru) Сульфониламинокарбонилпроизводные амидов холевой кислоты для применения в качестве иммуномодуляторов
JP5897461B2 (ja) ミエリン塩基性タンパク質のイメージング
RU2008125040A (ru) ПРОИЗВОДНЫЕ АРИЛ-ИЗОКСАЗОЛ-4-ИЛ-ИМИДАЗО[1.5-a]ПИРИДИНА
JP5014978B2 (ja) ヘテロ6員環化合物及びその用途
KR102174196B1 (ko) 소수성기가 도입된 실리콘-로다민 형광 프로브 및 이의 용도
WO2001021583A1 (en) Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
WO2025124439A1 (zh) Fap靶向放射性药物
WO2007111179A1 (ja) 神経難病の画像診断薬
JP5619740B2 (ja) メタロプロテアーゼの選択的診断剤
EP3160514B1 (en) Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
JPWO2010044411A1 (ja) フェニルイソニコチン酸誘導体及びその医薬用途
RU2009138346A (ru) Соединения, имеющие арилсульфонамидную структуру, применимые в качестве ингибиторов металлопротеаз
JP2007511582A5 (cg-RX-API-DMAC10.html)
JP2010189359A (ja) ベンゾチアゾール誘導体含有診断用組成物
JP2023545298A (ja) コキシブ由来の複合体化合物及びその使用方法
ES2523818T3 (es) Agente terapéutico para enfermedades neurológicas
JP5840128B2 (ja) Mmpインヒビターとしてのシュードジペプチド
JP5580204B2 (ja) ビアリールイソニコチン酸誘導体及びその医薬用途
JP2010521529A5 (cg-RX-API-DMAC10.html)
JPWO2014109296A1 (ja) 神経難病のmr画像診断薬
JP2009541262A5 (cg-RX-API-DMAC10.html)
JP2025529095A (ja) 化学コンジュゲート、組成物、およびその調製方法と使用
WO2018139438A1 (ja) フェニルジフルオロメチル置換プロリンアミド化合物